Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
HELSINN HEALTHCARE S.A. et al v. DR. REDDY'S LABORATORIES, LTD. et al
Case Number:
3:11-cv-03962
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 04, 2016
Judge Defines Scope Of On-Sale Bar Under AIA
A New Jersey federal judge has held that a licensing and supply agreement a small pharmaceutical company inked with an entity for the anti-nausea drug Aloxi did not trigger the “on-sale bar” under the America Invents Act.
-
November 16, 2015
Teva's Planned Generic Aloxi Infringes Helsinn IP, Judge Says
A New Jersey federal judge on Monday ruled that Teva Pharmaceuticals USA Inc. is infringing four patents covering Helsinn Healthcare SA's anti-nausea drug Aloxi and blocked Teva from releasing its planned generic version of the drug until 2024.